Helius Medical Technologies is trading at $2.36, up +5.36%, with healthcare-sector strength the strongest available explanation, though no direct cause is established. - Healthcare gained 2.12% during the regular session amid a rotation toward the sector. - No clear company-specific announcement or event for October 20, 2026, surfaced in search results; recent Helius-related results chiefly referenced older news or reporting about the ticker’s company identity.